
Intuitive Surgical (ISRG) Stock Forecast & Price Target
Intuitive Surgical (ISRG) Analyst Ratings
Bulls say
Intuitive Surgical is the global leader in robotic-assisted minimally invasive surgery, developing, producing, and marketing the da Vinci surgical system. With over 10,000 systems installed worldwide, including a growing number in emerging markets, and a highly profitable business model, the company has a strong foundation for continued growth. Increased adoption of robotic surgery in the healthcare industry, improved system utilization, and expanding indications for the SP and Ion systems are all factors that contribute to a positive outlook for this stock.
Bears say
Intuitive Surgical is facing downward pricing pressure on refurbished systems and a slowdown in international placements, leading to a decline in ASPs. Despite the positive feedback on Force Feedback and FDA clearances for additional uses of the instrumentation, continued growth in this area is not enough to offset other growth headwinds. While the potential for robotic surgery is promising, competition and margin compression in the near term hinder long-term profitability.
This aggregate rating is based on analysts' research of Intuitive Surgical and is not a guaranteed prediction by Public.com or investment advice.
Intuitive Surgical (ISRG) Analyst Forecast & Price Prediction
Start investing in Intuitive Surgical (ISRG)
Order type
Buy in
Order amount
Est. shares
0 shares